INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
16/08/2021
Voltar para busca
Dado oficial do USPTO
BISULFITOME
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BISULFITOME
ST13
US500000079066457Classe
1, 5, 9
Pedido
79066457
Registro
3828435
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
59
Atualização mais recente
16/08/2021
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 9
Data de depósito
04/11/2008
Data de registro
03/08/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/12/2020
Última transação
02/12/2020
Escritório responsável
United States Patent and Trademark Office
Código da situação
706
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
Hilden, DE
Examinador
ROSSMAN, WILLIAM M
Unidade examinadora
L90
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
QIAGEN GmbH
QIAGEN GmbH
Representantes
Victoria Friedman Dennemeyer & Associates, LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 9
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicalbiochemical and biotechnological products for scientific and laboratory research purposesnucleic acidsenzymes and polymererases for laboratory and research usediagnostic reagents and chemical buffers used for the isolationpurification or separation of nucleic acidsoligonucleotides or proteinsprotein arrays none of the foregoing for medical or veterinary purposes; chemical reagents and aromatic solvents for sample preparationmodification and manipulation of cells and for conducting markingseparatingisolatingpurifyingamplification and/or analytic methods for natural and synthetic biopolymersnucleic acidsoligonucleotidesproteinmacromolecules and biologically active substances in the nature of nucleic acids; kits comprised of chemicalbiochemical and biotechnological products for sample preparationpurificationmodification and manipulation of cells as well as for the performance of markingseparationisolationpurificationamplification and analysis of biopolymerskits comprised of nucleic acidsenzymesproteinsmacromolecules and biologically active substances in the nature of nucleic acids from biological and biochemical sample material; all for scientific or laboratory research purposes
Classe 5
Pharmaceutical and veterinary preparations for medical use including studies and research and development purposesnucleic acids sequenceschemical reagents and biochemical preparations; diagnostic preparations for medical purposes; diagnostic preparations for medical and veterinary purposesdiagnostic preparations for sample preparationmodification and manipulation of samples and cells and diagnostic preparations for markingseparatingisolatingpurifyingamplification and/or medical and veterinary analysis of biopolymersin the nature of nucleic acids sequencesoligo-nucleotide arraysprobesprimersaptamersantisense-oligonucleotidespromotersmicroRNA (miRNA)ribozymes; chemicalbiochemical and biotechnological preparations for medical usemedical and veterinary diagnostic reagents and solvents for medical and veterinary use for sample preparationmodification and manipulation of samples and cells and medical and for conducting markingseparatingisolatingpurifyingamplifying and/or analysis of biopolymersin the nature of nucleic acid sequencesprotein arraysmacromolecules and biologically effective substances in the nature of nucleic acid sequences all for diagnostic medical purposes; in vitro diagnostics reagents for medical purposes; kits comprising diagnostic preparations for medical or veterinary diagnostic purposesfor medical and veterinary sample preparationmodification and manipulation of cells and for markingseparatingisolatingpurifyingamplification and/or for the analysis of biopolymersin the nature of nucleic acid sequencesoligo-nucleotide arraysprobesprimersaptamersantisense-oligonucleotidespromotersmicroRNA (miRNA)ribozymesproteinsmacromolecules and biologically effective substances in the nature of nucleic acid sequences from biological and biochemical sample materials; all-purpose disinfectants
Classe 9
Scientific apparatusesinstruments and devices for the purpose of surveyingweighingmeasuringsignaling and regulating apparatusesinstruments and devices for researchlaboratory and scientific purposesdisposable bottle liners for use with laboratory apparatus; disposable and re-useable dispenser syringes for laboratory use; scalesplastic sample storagereaction and collection vesselsplates and multi-well plates that can be used in chemical analysisbiological analysis or patterning for scientificlaboratory or medical research use; laboratory consumablespipette tipsfilter tips and dispenser tipspipette tips and carrying pipette tip boxes; laboratory storage tubestest tubesmicro tubes and tubes for Polymerase Chain Reaction (PCR); micro-laboratory centrifuges and laboratory micro-injectors; laboratory equipment namelycuvettesspin columnschromatography columns and cartridges filled with chromatographic materials for the purpose of separationpurification and isolation of biopolymersnucleic acidsoligonucleotidesproteinsmacromolecules and biologically active substances in the nature of nucleic acids from biological and biochemical sample materials for scientific or laboratory use; racks and holders for sample laboratory storage tubes and beakerstubessyringes and pipette tips; scientific instrument used in laboratory sample preparationmagnetic beads for magnetic particle separation and handling and analyzing nucleic acidsproteinsenzymeschemicals; laboratory filtersfilter membranes for biotechnological and scientific purposesfilter membranes and filter devices comprised of laboratory spin columnstubesplatessilica materials and filter strips in a microtitration format for the isolation and purification of nucleic acids and oligonucleotidesother biological materials for laboratory and scientific use; sample presentation deviceslaboratory research micro-arrayssilicon chipsMatrix-Assisted Laser Desorption/Ionization (MALDI) presentation devicelaser desorption plates for analyzingdiagnosing and presenting data in the field of spectrometry all used for laboratory or medical research; laboratory robots and robotic workstations comprising computer hardware for laboratory robots; laboratory incubators for diagnosticclinical and research applications for the preparationmodificationisolationcrystallizationhandlingamplification and manipulation of samples and for the markingseparationisolationpurificationreproduction and analysis of biopolymersnucleic acidsoligonucleotidesproteinsmacromolecules and biologically active substances from sample material; laboratory apparatus and equipmentcomputer hardware and software for dosagedispensingtransferringtemperature equalizingagitatingmixingdilutingconcentrating and separating of liquids; laboratory apparatusMALDI laser desorption plates for use in analytical analysismedicaldiagnostic and research workstations comprised of computer hardware and software for reading and handling multi-well plates for the analysis of biopolymersnucleic acidsoligonucleotidesproteinsmacromolecules and biologically active substances from sample materials; laboratory equipmentthermal cyclers and cell disrupters; physico-chemicalbiochemicaloptical and electronic analysis apparatuses and equipmentphotometersspectrophotometersoptical scanners for detection of fluorescence and colorimetric signals; apparatuses and instruments for processing cells or liquids containing cells namelyelectroporatorsmicro-injectors and micro-manipulators; scientific apparatusultra high vacuum chambers for chromatographypurificationseparation and characterization of natural and synthetic biopolymersnucleic acidsoligo-nucleotidesproteinsmacromolecules and biologically active substances from sample materials; centrifuges for laboratory use; vacuum manifold and one or more membrane holders for filtration of liquids for laboratory use; scientific apparatus for laboratory usecentrifugal vacuum concentrators designed to separateconcentratecentrifuge and dry biological and chemical materials; rotors for laboratory centrifuges and vacuum concentrators and microtube mixers for laboratory use; mechanicalelectronic and automatic pipettes and dispensers for dispensing liquid for laboratory research and analysis purposes
Publicações
Histórico de despachos e eventos da marca no USPTO.
59 publicações encontradas
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
02/08/2021
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
02/12/2020
71AG
REGISTERED-SEC.71 ACCEPTED
02/12/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/11/2020
ES71
TEAS SECTION 71 RECEIVED
31/07/2020
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
03/08/2019
RNWL
INTERNATIONAL REGISTRATION RENEWED
22/11/2018
NREP
NEW REPRESENTATIVE AT IB RECEIVED
18/10/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
23/06/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
04/05/2017
INPC
INVALIDATION PROCESSED
04/05/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
29/04/2017
NA75
NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
29/08/2016
C75P
REGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.
29/08/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
25/08/2016
ES75
TEAS SECTION 71 & 15 RECEIVED
19/07/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
22/08/2014
NREP
NEW REPRESENTATIVE AT IB RECEIVED
12/07/2013
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/02/2013
FICS
FINAL DISPOSITION NOTICE SENT TO IB
05/11/2010
FIMP
FINAL DISPOSITION PROCESSED
05/11/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/11/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
03/08/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
18/05/2010
PUBO
PUBLISHED FOR OPPOSITION
18/05/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
12/04/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/04/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
10/04/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/04/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
10/04/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/04/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/04/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/04/2010
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
05/04/2010
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
05/03/2010
GNCF
CONTINUATION OF FINAL REFUSAL E-MAILED
05/03/2010
CNCF
ACTION CONTINUING A FINAL - COMPLETED
05/03/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/02/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/02/2010
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
17/02/2010
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
27/08/2009
GNFR
FINAL REFUSAL E-MAILED
27/08/2009
CNFR
FINAL REFUSAL WRITTEN
27/08/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/08/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/08/2009
ALIE
ASSIGNED TO LIE
03/08/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/07/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/07/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/07/2009
RFNT
REFUSAL PROCESSED BY IB
15/05/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
21/04/2009
RFRR
REFUSAL PROCESSED BY MPU
21/04/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
19/04/2009
CNRT
NON-FINAL ACTION WRITTEN
18/04/2009
MAFR
APPLICATION FILING RECEIPT MAILED
14/04/2009
DOCK
ASSIGNED TO EXAMINER
10/04/2009
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/04/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/04/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BISULFITOME ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.